Healthcare provider profile · identity verified

Grazyna Sulewska, AGNP

Nurse Practitioner · SEA GIRT, NJ · NPI 1922768340

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	212	48
Furosemide	Furosemide	204	69
Pantoprazole Sodium	Pantoprazole Sodium	178	50
Levothyroxine Sodium	Levothyroxine Sodium	172	31
Metformin Hcl	Metformin Hcl	147	27
Alprazolam	Alprazolam	90	34
Eliquis	Apixaban	83	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	13
Divalproex Sodium	Divalproex Sodium	70	14
Potassium Chloride	Potassium Chloride	70	24
Mirtazapine	Mirtazapine	69	20
Gabapentin	Gabapentin	66	18
Sertraline Hcl	Sertraline Hcl	64	11
Lisinopril	Lisinopril	57	14
Amlodipine Besylate	Amlodipine Besylate	56	16
Cefuroxime	Cefuroxime Axetil	49	40
Metoprolol Tartrate	Metoprolol Tartrate	48	15
Famotidine	Famotidine	46	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	46	suppressed
Losartan Potassium	Losartan Potassium	46	12
Tramadol Hcl	Tramadol Hcl	45	21
Nystatin	Nystatin	43	19
Trazodone Hcl	Trazodone Hcl	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Simvastatin	Simvastatin	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	29	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Metoprolol Succinate	Metoprolol Succinate	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	23
Spironolactone	Spironolactone	27	suppressed
Pregabalin	Pregabalin	26	suppressed
Loperamide	Loperamide Hcl	25	19
Mupirocin	Mupirocin	25	15
Cephalexin	Cephalexin	23	18
Lorazepam	Lorazepam	23	12
Memantine Hcl	Memantine Hcl	23	suppressed
Prednisone	Prednisone	23	11
Bumetanide	Bumetanide	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	12
Hydrochlorothiazide	Hydrochlorothiazide	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	18
Buspirone Hcl	Buspirone Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Risperidone	Risperidone	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Nystop	Nystatin	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	13	11
Ammonium Lactate	Ammonium Lactate	13	suppressed
Azithromycin	Azithromycin	13	12
Colestipol Hcl	Colestipol Hcl	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Glipizide	Glipizide	12	suppressed
Lactulose	Lactulose	12	suppressed
Omeprazole	Omeprazole	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Atenolol	Atenolol	11	suppressed
Carvedilol	Carvedilol	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Jardiance	Empagliflozin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error